ArticleBlood advances2023

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.

Renato Bassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.